Internal Quality Control：
- Evaluate laboratory testing capabilities
- Monitor laboratory test results
External Quality Control：
-Monitoring differences in detection capabilities between laboratories
New Diagnostic Product Performance Evaluation：
-Performance verification
-Real-time detection monitoring
Compatibility Performance Verification：
-New project study in Hospitals, Microbiology research institutes
-Different IVD manufacturers' products matching study
Lyophilized Form
➢ No cold-chain transportation required
Inactivated Pathogens
➢ Non-infectiou, Control for full PCR test step
With Whole Genome
➢ Mimic a true clinical specimen
Tracebale Copy of Analyse
➢ Quantification by digital PCR technology, reliable analysis report attached
| No. | Pathogen | Strains |
|---|---|---|
| 1 | Respiratory Syncytial Virus | A; B |
| 2 | Dengue virus | 1,2,3,4 |
| 3 | Human herpes virus | 1,2,3,4,5 |
| 4 | Norovirus | G1,G2,GII |
| 5 | Parainfluenza virus | 1,2,3,4,4a,4b |
| 6 | Human parapneumovirus | A2,B1,B2 |
| 7 | Echovirus | 6,7,9,30,70 ,71 |
| 8 | Coronavirus | 229E ,MERS (N+ ORF1ab) |
| 9 | Coronavirus SARS-CoV-2 | N , ORF1ab , N+ORF1ab |
| 10 | Influenza B virus | Victoria, Yamagata |
| 11 | Influenza A virus | H1/H3/2009 H1N1/H1N1/H3N2 |
| 12 | Adenovirus | 1/2/3/4/5/6/7/11/14/21/35/40/41/55 |
| 13 | Coxsackie virus | A2/A4/A5/A6/A7/A9/A10/A12/A16/A24/ B1/B2/B3/B4/B5/B6 |
| 14 | Rhinovirus | A2/A21/A30/A31/A54/A58/A63/A78/A81/A89/ B52/B70/B72 |
| 15 | HPV gDNA | 6/11/16/18/26/31/33/35/39/40/42/43/44/45/51/52 /53/54/56/58/59/61/66/68/69/70/73/81/82/83 |
| 16 | Boca virus | / |
| 17 | Canine distempervirus | / |
| 18 | Chlamydia pneumoniae | / |
| 19 | Rubella virus | / |
| 20 | Cytomegalovirus | / |
| 21 | Hepatitis A virus | / |
| 22 | Hepatitis A virus | / |
| 23 | Zika virus | / |
| 24 | Measles virus | / |
| 25 | Metapneumovirus | / |
| 26 | Mumps virus | / |
| 27 | Coronavirus SARS (N+ORF1ab) | / |
And More............................
